How are you viewing this Fed rate cut coming up or the expected Fed rate come coming up. It seems like it's all but certain, but certainly we don't know for a fact that it's going to happen. Just 90% chance according to the CME.Is it going to be a hawkish cut or a dobish cut and how much does that matter for the market at least from now until the end of the year. >> Yeah, I think tomorrow, you know, it's very likely. I think there has been a lot of back and forth uh from market pricing for the last couple o ...

Core Insights - Nvidia's partnerships with Eli Lilly and Johnson & Johnson highlight a growing trend in the pharmaceutical industry to leverage AI for accelerating drug discovery and enhancing healthcare operations [1][4]. Group 1: AI in Drug Discovery - Eli Lilly aims to expedite drug discovery processes by creating a new Nvidia-chip powered "supercomputer" and "AI factory" set to launch by early 2026, utilizing AI models trained on extensive experimental data [3]. - The average cost and time for new drug discovery exceed $2 billion and over a decade, respectively, indicating a significant opportunity for AI to streamline these processes [2]. Group 2: Applications in Healthcare - Johnson & Johnson's partnership with Nvidia focuses on using AI to create simulated environments for surgical teams, enhancing training and improving clinical outcomes [4]. - The potential for generative AI in the pharmaceutical and medical products sectors could unlock tens of billions in value by improving drug discovery, clinical trials, and treatment administration [5]. Group 3: Customization and Specificity - There is a growing demand for AI solutions tailored to specific business needs within the pharmaceutical industry, moving away from generic platforms [7][8]. - Eli Lilly's Chief AI Officer emphasizes the importance of proprietary data and customized AI models to drive significant advancements in drug discovery [8]. Group 4: Future of AI in Surgery - The integration of physical AI in surgical settings could lead to a hybrid model where human surgeons collaborate with robots and digital agents, potentially transforming surgical techniques [10][11]. - The World Health Organization projects a global shortfall of 11 million health workers by 2030, underscoring the need for AI to assist in healthcare delivery [10].

Core Viewpoint - Nvidia has experienced significant stock growth due to its leading position in the AI chip market, but Meta Platforms is predicted to outperform Nvidia in 2026 as it focuses on AI integration and advertising revenue growth [2][3][14]. Nvidia - Nvidia's stock has surged over 1,000% in the past three years and has increased by 43% since the beginning of 2023, driven by its dominant AI chip sales [2]. - The company has seen explosive earnings growth, with forecasts suggesting the AI market could expand from billions to trillions, supporting Nvidia's continued growth [3]. Meta Platforms - Meta Platforms is recognized as a key player in the AI growth narrative, prioritizing investments in AI technology to enhance its applications and advertising capabilities [4][5]. - The company has a vast user base of approximately 3.5 billion daily users across its platforms, making it an attractive option for advertisers [5]. - Meta's financial strength is evident, with revenue and profit growth into the billions, and it also offers dividends, which is uncommon for high-growth tech firms [6]. - Despite concerns about overcapacity in AI investments, CEO Mark Zuckerberg indicated strong demand for additional computing resources, suggesting a strategic approach to infrastructure spending [7][8]. - Meta is currently the cheapest stock among the "Magnificent Seven" tech stocks, having only advanced about 7% this year, which may attract investors looking for value [9][11]. - The company's focus on responsible AI investment and strong earnings could lead to increased stock performance in the future [11].

Trade Relations - The Trump administration has announced a one-year agreement with China regarding rare earths and critical minerals, alongside a reduction in fentanyl-related tariffs from 20% to 10% effective immediately [4] - Overall tariffs on Chinese exports will decrease from 57% to 47% [4] - In exchange, China will work to halt fentanyl production and resume purchases of American agricultural products, including soybeans [5] Technology Sector - Discussions included the sales of Nvidia chips to China, with Nvidia being a significant player in the semiconductor market valued at $5 trillion [5] - The meeting did not cover sales of Nvidia's latest Blackwell accelerators to China [5] IPO Developments - OpenAI is reportedly preparing for an initial public offering that could value the company at up to $1 trillion, with plans to file with regulators as early as the second half of 2026 [7] - The company aims to raise $60 billion at the lower end, with a potential earlier listing in late 2026 [7][8] Microsoft Azure Outage - Microsoft has resolved an Azure cloud platform outage that lasted over 8 hours, affecting various global businesses and services [8] - Companies like Alaska Airlines and Heathrow Airport experienced disruptions due to the outage [9]

Market Overview - The ongoing government shutdown is causing volatility in the markets, with the S&P 500 and NASDAQ 100 remaining positive, while the Dow is slightly weaker [1][2][3] - Small-cap stocks are also experiencing similar trends, indicating a mixed market response to the shutdown [2][3] Asset Class Performance - There is a rebound in gold and Bitcoin, suggesting continued investment flows despite the shutdown [4] - The liquidity in the market is high, with significant capital seeking investment opportunities, which may lead to a risk-on mentality if the shutdown is resolved soon [5] Economic Indicators - Consumer sentiment data is expected to be released, but recent trends show a decline in these numbers, which may not significantly impact the equity markets [6][9] - The prediction markets indicate a likelihood of the government shutdown lasting closer to a month, which could pressure lawmakers to reach a resolution [7][8] Federal Reserve Insights - The Federal Reserve is closely monitoring consumer sentiment and other economic indicators, with potential rate cuts already priced in by the markets [10][11] - The selection process for the new Fed chair is ongoing, with several candidates being considered, including Michelle Bowman and Waller, while Rick Reer is emerging as a potential dark horse [13][17][19] Company Focus: Nvidia - Nvidia's stock has reached record highs despite challenges related to China’s import controls on chips, indicating strong demand for their products [20][25] - The company is navigating complex negotiations with China, which may impact future sales and market dynamics [22][24]

Core Viewpoint - CoreWeave's IPO performance and initial trading day struggles may not reflect the overall AI industry's health, as the company's issues are largely self-inflicted [1][5]. Company Overview - CoreWeave is the first publicly listed "pure AI company" since the launch of OpenAI's ChatGPT in 2022, acting as a catalyst for the AI boom [2]. - The company operates data centers that provide specialized Nvidia chips for running AI workloads [1]. Financial Performance - CoreWeave initially aimed to raise approximately $4 billion through its IPO with a valuation of $35 billion, but due to insufficient investor interest, it reduced the fundraising target to $1.5 billion and the valuation to about $19 billion [5]. - On its first trading day, the stock price fell from the $40 issuance price but later stabilized around that price, indicating a lackluster market debut [5]. Business Model and Debt - CoreWeave's business model heavily relies on debt to build data center capacity, which exceeds actual demand [7]. - The company has borrowed $8 billion to lease data centers and equip them with Nvidia GPUs, which are essential for AI applications [8]. - Analysts predict that by 2025, CoreWeave will need to pay at least $1 billion in debt service fees, potentially rising to $1.7 billion due to interest rate changes and business factors [9]. - The company currently has about $4.4 billion in debt that has not yet been drawn [10]. Asset Depreciation and Cash Flow - CoreWeave's GPUs are depreciating assets, with the current generation (Hopper series) being replaced by newer models (Blackwell series), leading to a decline in rental prices [12]. - The company has a $2.6 billion obligation for operating leases with an average lease term of 9 years, requiring $213 million in payments by the end of 2024 [15]. - CoreWeave's cash burn rate is alarming, having generated $2.75 billion in cash while spending $8.7 billion on leasing data centers and GPUs [16]. Customer Dependency - CoreWeave is highly dependent on two clients, Microsoft and Nvidia, which together account for over 75% of its revenue, with Microsoft alone contributing 60% [19][20]. - Microsoft has begun to reduce spending with CoreWeave due to service delivery issues, leading to contract cancellations [20]. Market Position and Competition - CoreWeave's reliance on raw GPU capacity limits its customer base to those who specifically need such services, unlike traditional cloud service providers that offer a broader range of services [24]. - Major cloud providers like Microsoft and Google Cloud have reported significant revenue growth (30% for Microsoft and Google Cloud, 19% for AWS) attributed to AI adoption, indicating a healthy market despite CoreWeave's struggles [27][28]. Industry Outlook - The emergence of companies like DeepSeek, which can achieve advanced AI capabilities with less hardware, raises questions about the future demand for GPU resources [31]. - The profitability of companies developing foundational AI models remains uncertain, as the rapid replication of these models by competitors leads to declining prices and potential financial instability [32].